文献速递肝病

分子力诱导解放转化生长因子-β重塑脾脏用于异位肝再生

Molecular force-induced liberation of transforming growth factor-beta remodels the spleen for ectopic liver regeneration.
PubMed 文献 · J Hepatol · 2024-01-18

研究合成对潜在转化生长因子-β(TGF-β)复合物有亲和力的硫酸化透明质酸(sHA),经点击化学交联为凝胶网络(sHA-X),注入小鼠脾脏以超生理水平激活内源性TGF-β诱导脾组织重塑。sHA-X结合脾内丰富的潜在TGF-β并提供分子力释放活性TGF-β二聚体,模拟生理激活的「结合-牵拉」机制。移植入重塑脾脏的肝细胞形成足够体积的肝组织,挽救代谢性肝病(Fah-/-转基因模型)或90%肝切除动物,未观察到不良效应且无需额外药物。

要点

  • sHA-X经点击化学交联,可结合脾内丰富的潜在TGF-β并提供分子力释放活性TGF-β二聚体。
  • sHA-X重塑脾脏后移植肝细胞可形成肝组织,挽救Fah-/-代谢性肝病模型或90%肝切除动物。
  • 研究中未观察到不良效应,且无需额外药物。

核心结论

  • 研究结果突出sHA-X通过机械激活单一细胞因子重塑特定器官的有效性和转化潜力,代表基于生物材料的器官再生治疗设计新策略。

研究设计与样本

  • 研究合成硫酸化透明质酸(sHA)并经点击化学交联为凝胶网络(sHA-X),注入小鼠脾脏诱导脾组织重塑。
  • 在Fah-/-转基因代谢性肝病模型及90%肝切除动物中评估移植肝细胞形成的肝组织对动物的挽救作用。

主要发现

  • sHA-X高效结合脾内丰富的潜在TGF-β,并提供分子力将活性TGF-β二聚体从潜在复合物中释放,模拟生理激活所需的「结合-牵拉」机制。
  • sHA-X重塑脾组织以支持肝细胞生长,移植入重塑脾脏的肝细胞发育为足够体积的肝组织。
  • 在Fah-/-转基因模型或90%肝切除动物中,移植肝细胞形成的肝组织足以挽救动物,未观察到不良效应且无需额外药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Ectopic liver regeneration in the spleen is a promising alternative to organ transplantation for treating liver failure. To accommodate transplanted liver cells, the splenic tissue must undergo structural changes to increase extracellular matrix content, demanding a safe and efficient approach for tissue remodelling. METHODS: We synthesised sulphated hyaluronic acid (sHA) with an affinity for the latent complex of transforming growth factor-β (TGF-β) and cross-linked it into a gel network (sHA-X) via click chemistry. We injected this glycan into the spleens of mice to induce splenic tissue remodelling via supraphysiological activation of endogenous TGF-β. RESULTS: sHA-X efficiently bound to the abundant latent TGF-β in the spleen. It provided the molecular force to liberate the active TGF-β dimers from their latent complex, mimicking the 'bind-and-pull' mechanism required for physiological activation of TGF-β and reshaping the splenic tissue to support liver cell growth. Hepatocytes transplanted into the remodelled spleen developed into liver tissue with sufficient volume to rescue animals with a metabolic liver disorder (Fah-/- transgenic model) or following 90% hepatectomy, with no adverse effects observed and no additional drugs required. CONCLUSION: Our findings highlight the efficacy and translational potential of using sHA-X to remodel a specific organ by mechanically activating one single cytokine, representing a novel strategy for the design of biomaterials-based therapies for organ regeneration. IMPACT AND IMPLICATIONS: Cell transplantation may provide a lifeline to millions of patients with end-stage liver diseases, but their severely damaged livers being unable to accommodate the transplanted cells is a crucial hurdle. Herein, we report an approach to restore liver functions in another organ - the spleen - by activating one single growth factor in situ. This approach, based on a chemically designed polysaccharide that can mechanically liberate the active transforming growth factor-β to an unusually high level, promotes the function of abundant allogenic liver cells in the spleen, rescuing animals from lethal models of liver diseases and showing a high potential for clinical translation.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Wang Z, Xie D, Li J, et al. Molecular force-induced liberation of transforming growth factor-beta remodels the spleen for ectopic liver regeneration. J Hepatol. 2024. PMID: 38244845. doi:10.1016/j.jhep.2024.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。